Editorial: surviving your genes-the role of PNPLA3 variation in end-stage liver disease. Authors' reply

Aliment Pharmacol Ther. 2018 Oct;48(7):775-776. doi: 10.1111/apt.14932.

Authors

Mattias Mandorfer¹, Bernhard Scheiner¹, Thomas Reiberger¹, Arnulf Ferlitsch^{1

2}; Vienna Hepatic Hemodynamic Lab

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
² Department of Internal Medicine I, Hospital of St. John of God, Vienna, Austria.

PMID: 30246307
DOI: 10.1111/apt.14932

No abstract available

Publication types

Editorial
Comment

MeSH terms

End Stage Liver Disease*
Genotype
Humans
Hypertension, Portal*
Phospholipases

Substances

Phospholipases